Drawing for THE SCIENCE OF UNDERSTANDING

USPTO serial 88381289

THE SCIENCE OF UNDERSTANDING

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MARCY, AMY ALFIERI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE SCIENCE OF UNDERSTANDING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marsha K. Hoover

Marsha K. Hoover GOLDBERG KOHN LTD.55 EAST MONROE, SUITE 3300CHICAGO, IL 60603UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Genomic tests for medical or clinical purposes, namely, genomic tests comprised primarily of reagents for medical or clinical purposes; genomic tests for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans, namely, Genomic tests comprised primarily of reagents for medical or clinical purposes used to collect test samples for analyzing DNA information for use in DNA testing of humans; kits for use in genetic testing for medical or clinical purposes, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes; kits for use in genetic testing for medical or clinical purposes in DNA testing of humans, namely, kits comprised of reagents for use in genetic testing for medical or clinical purposes in DNA testing of humansACTIVE—
035Providing referrals in the field of physician services; retail pharmacy servicesACTIVE—
036Charitable fundraising services in the field of medicineACTIVE—
038Providing access to databases that enable users to access patient diagnostic health information, medical reports, and educational information in the area of medicineACTIVE—
039Arranging of passenger transportation services for others; transport of passengers related to health care servicesACTIVE—
041Educational services, namely, providing courses of instruction in the field of medicine and healthcare through a medical school and providing continuing medical education coursesACTIVE—
042Medical and scientific research, namely, conducting clinical trials for others and translational research, namely, medical research involving the translation of findings in scientific research to medical practice; providing scientific analysis and informational reports in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases; reporting services based upon the results of laboratory testing in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseasesACTIVE—
044Medical and health care services, namely, hospital services, medical clinic services, medical clinics, physician services, home health care and hospice services, medical laboratory services and medical testing services for diagnostic or treatment purposes, and nursing care services; provision of home healthcare services; hospital and healthcare services; medical care, specifically, hospital and health care services; physician services; health care services; hospitals; managed health care services; medical services; medical clinics; medical counseling services; providing medical profile and medical record analysis and assessments that are designed to identify characteristics that may be indicative of diseases before a patient is diagnosed; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; genetic testing for medical purposes, namely, medical tests that measure, analyze, and interpret genes of patients; personalized medical testing services, namely, pharmacogenomics testing services for diagnostic or treatment purposes; providing medical information, consultancy, and advisory services; medical information services, namely, preparation and generation of reports for the foregoing testing services through proprietary software applications; pharmacogenomics testing for diagnostic or treatment services; providing medical information to pathologists, physicians, and other healthcare practitioners with respect to tests, test results, test analysis, test trends, test effectiveness, test advisability, test selection, test ordering, test ordering management, test ordering procedures, test ordering efficiency, test ordering effectiveness, medical condition, health condition, and diagnosis in the fields of pathology, genetics, and pharmacogenomicsACTIVE—
045Organizing and conducting support groups relating to health issuesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 28, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 28, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 27, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 25, 2020EX2GSOU EXTENSION 2 GRANTED—
Nov 25, 2020EXT2SOU EXTENSION 2 FILED—
Nov 25, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 22, 2020EX1GSOU EXTENSION 1 GRANTED—
May 22, 2020EXT1SOU EXTENSION 1 FILED—
May 22, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 29, 2019ALIEASSIGNED TO LIE—
Aug 13, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2019DOCKASSIGNED TO EXAMINER—
Apr 29, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance